405 related articles for article (PubMed ID: 23727419)
1. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles.
Kawai N; Sato M; Minamiguchi H; Ikoma A; Sanda H; Nakata K; Sato H; Sakaguchi H; Nakai M; Sonomura T
J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea.
Ikeda M; Arai Y; Park SJ; Takeuchi Y; Anai H; Kim JK; Inaba Y; Aramaki T; Kwon SH; Yamamoto S; Okusaka T; ;
J Vasc Interv Radiol; 2013 Apr; 24(4):490-500. PubMed ID: 23466316
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization for unresectable hepatocellular carcinoma: A comparison of the efficacy and safety of 2 embolic agents.
Chen S; Yu W; Zhang K; Liu W; Chen Q
Medicine (Baltimore); 2018 May; 97(21):e10832. PubMed ID: 29794774
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma supplied from the short gastric artery: treatment with chemoembolization.
Jeon UB; Lee JW; Baik SK; Kim TU; Choo KS; Kim KI; Kim YW; Moon TY
Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1512-4. PubMed ID: 22532333
[TBL] [Abstract][Full Text] [Related]
5. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
[TBL] [Abstract][Full Text] [Related]
6. Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE).
Iezzi R; Cesario V; Siciliani L; Campanale M; De Gaetano AM; Siciliano M; Agnes S; Giuliante F; Grieco A; Pompili M; Rapaccini GL; Gasbarrini A; Bonomo L;
Radiol Med; 2013 Jun; 118(4):555-69. PubMed ID: 23358819
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter arterial chemotherapy using miriplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
Imai N; Ikeda K; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Jpn J Clin Oncol; 2012 Mar; 42(3):175-82. PubMed ID: 22210921
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter arterial chemoembolization for hepatocellular carcinoma: prospective assessment of the right inferior phrenic artery with C-arm CT.
Kim HC; Chung JW; Park JH; An S; Son KR; Seong NJ; Jae HJ
J Vasc Interv Radiol; 2009 Jul; 20(7):888-95. PubMed ID: 19481471
[TBL] [Abstract][Full Text] [Related]
9. Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and Outcome.
Miyayama S; Matsui O
J Vasc Interv Radiol; 2016 Sep; 27(9):1269-1278. PubMed ID: 27345337
[TBL] [Abstract][Full Text] [Related]
10. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
[TBL] [Abstract][Full Text] [Related]
11. 350-560 μm gelatin sponge particles combined with transcatheter arterial chemoembolization for the treatment of elderly hepatocellular carcinoma: The safety and efficacy.
Zhao GS; Li C; Liu Y; Ren ZZ; Yuan XL; Zhou J; Zhang YW; Zhang M
Medicine (Baltimore); 2017 Apr; 96(16):e6629. PubMed ID: 28422858
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
Sahara S; Kawai N; Sato M; Tanaka T; Ikoma A; Nakata K; Sanda H; Minamiguchi H; Nakai M; Shirai S; Sonomura T
Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1363-71. PubMed ID: 22358993
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and Safety of Repeated Transarterial Chemoembolization Using Miriplatin-Lipiodol Suspension for Hepatocellular Carcinoma.
Matsumoto T; Ichikawa H; Imai J; Hayashi T; Tomita K; Mine T; Kojima S; Watanabe N; Hasebe T
Anticancer Res; 2017 Jun; 37(6):3183-3187. PubMed ID: 28551662
[TBL] [Abstract][Full Text] [Related]
15. A new soluble gelatin sponge for transcatheter hepatic arterial embolization.
Takasaka I; Kawai N; Sato M; Sahara S; Minamiguchi H; Nakai M; Ikoma A; Nakata K; Sonomura T
Cardiovasc Intervent Radiol; 2010 Dec; 33(6):1198-204. PubMed ID: 20431885
[TBL] [Abstract][Full Text] [Related]
16. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study.
Caturelli E; Siena DA; Fusilli S; Villani MR; Schiavone G; Nardella M; Balzano S; Florio F
Radiology; 2000 Apr; 215(1):123-8. PubMed ID: 10751477
[TBL] [Abstract][Full Text] [Related]
18. Chemoembolization for hepatocellular carcinoma: epinephrine followed by a doxorubicin-ethiodized oil emulsion and gelatin sponge powder.
Clouse ME; Stokes KR; Kruskal JB; Perry LJ; Stuart KE; Nasser IA
J Vasc Interv Radiol; 1993; 4(6):717-25. PubMed ID: 7506597
[TBL] [Abstract][Full Text] [Related]
19. Computed tomographic perfusion imaging for the therapeutic response of chemoembolization for hepatocellular carcinoma.
Yang L; Zhang XM; Tan BX; Liu M; Dong GL; Zhai ZH
J Comput Assist Tomogr; 2012; 36(2):226-30. PubMed ID: 22446364
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma.
Takaki S; Sakaguchi H; Anai H; Tanaka T; Yamamoto K; Morimoto K; Nishiofuku H; Inoue M; Sueyoshi S; Nagata T; Hidaka T; Uchida H; Kichikawa K
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):544-54. PubMed ID: 21739345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
